• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

New mutations behind heritable hypercalcemia and hypocalcemia identified

byAndrew Bishara
June 27, 2013
in Chronic Disease, Nephrology
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Image: PD G protein coupled receptor

1. Loss-of-function mutations in Gɑ11 cause type 2 familial hypocalciuric hypercalcemia.

2.  Gain-of-function mutations in Gɑ11 can cause autosomal dominant hypocalcemia

Study Rundown: The calcium-sensing receptor (CaSR) is expressed in two key regulators of calcium homeostasis: the parathyroid and the kidney. High levels of calcium activate CaSR, leading to inhibition of parathyroid hormone (PTH) release and reduced calcium reabsorption in the renal tubules. CaSR, in effect, determines the body’s calcium set point.

In type 1 familial hypocalciuric hypercalcemia, the body’s calcium set point is increased by loss-of-function mutations in CaSR. On the other hand, CaSR gain-of-function mutations lower the calcium set point. This is known as autosomal dominant hypocalcemia.

Since CaSR is a G-protein coupled receptor (GPCR), the authors hypothesized that inactivating and activating mutations in the coupled G-protein, Gɑ11, could cause subtypes of FHH and autosomal dominant hypocalcemia, respectively.

Indeed, a Gɑ11 loss-of-function mutation was found in a family with type 2 FHH and Gɑ11 gain-of-function mutations were identified in 2 individuals with autosomal dominant hypocalcemia.

RELATED REPORTS

ACKR1 variant increases risk of azathioprine-related hematopoietic toxicity

2 Minute Medicine Rewind June 20, 2022

#VisualAbstract: Whole-genome sequencing changes clinical management in significant number of critically ill infants

Click to read the study in the New England Journal of Medicine

Relevant Reading: Diseases associated with the extracellular calcium-sensing receptor

In-Depth [genetic study]: A 3-base pair deletion in the gene encoding Gɑ11 was found to co-segregate with the disease in a family with type 2 FHH. A missense mutation in the gene was also identified in an unrelated individual with FHH. In vitro, these mutations were shown to reduce the sensitivity of cells to extracellular calcium, suggesting a loss of function in Gɑ11. Protein modeling suggests that the mutations inhibit the enzyme’s ability to transition to its active state.

The authors were also able to find missense mutations in Gɑ11 in two patients with hypocalcemia. In vitro studies showed that these mutations increased the sensitivity of cells to extracellular calcium – a gain of function. Protein modeling suggests that the mutations prolong the time Gɑ11 spends in its active GTP-bound state.

This study provides convincing evidence for the role of Gɑ11 in forms of hypercalcemia and hypocalcemia by combining genetic, in vitro and protein modeling data. However, Gɑ11 mutations are not the final word on FHH or autosomal dominant hypocalcemia. Only 3 of the 18 unrelated patients tested had Gɑ11 mutations. The mutations in the other 15 remain unknown.

By Tomi Jun and Mitalee Patil

More from this author: Researchers improve lung cancer risk model by incorporating more risk factors, Study hints at causal link between lipoprotein(a) and calcific aortic stenosis, Peginasetide non-inferior to EPO for chronic kidney disease patients not on dialysis [PEARL Trials],Video surveillance sheds light on causes of falls in the elderly, [In the News] Extended tamoxifen regimen reduces mortality for subset of breast cancer, [Researcher Comment] Whole-genome sequencing helps halt MRSA bacterial outbreak, [In The News] Modest protection conferred by malaria vaccine in phase 3 trial, [Physician Comment] Multiple sclerosis: Anti-cancer drug beats current first-line treatment in phase 3 trial, A molecular link between sleep deprivation and insulin resistance, A phase I trial of neural stem cells in a disease of myelination shows promising results, Diagnostic exome sequencing in persons with severe intellectual disability finds new candidate genes, HPV vaccine associated with minimal adverse effects, Four different types of breast cancer revealed based on molecular data, Acupuncture helpful for chronic pain: new meta-analysis [Arch Intern Med.]

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: autosomal dominantcalcium-sensing receptorendocrinologyFHHgeneticshypercalcemiahypocalcemianephrologyparathyroid hormonePTH
Previous Post

Lifestyle intervention in obese diabetics does not affect cardiovascular events

Next Post

Neoadjunctive radiotherapy, hospital factors key for rectal cancer resection

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

ACKR1 variant increases risk of azathioprine-related hematopoietic toxicity

June 30, 2022
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Weekly Rewinds

2 Minute Medicine Rewind June 20, 2022

June 20, 2022
#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication
StudyGraphics

#VisualAbstract: Whole-genome sequencing changes clinical management in significant number of critically ill infants

June 10, 2022
Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis
Weekly Rewinds

2 Minute Medicine Rewind May 30, 2022

May 30, 2022
Next Post
Neoadjunctive radiotherapy, hospital factors key for rectal cancer resection

Neoadjunctive radiotherapy, hospital factors key for rectal cancer resection

Patient transfers to trauma centers often unnecessary

Patient transfers to trauma centers often unnecessary

Open carpal tunnel release provides long-term symptom relief

Open carpal tunnel release provides long-term symptom relief

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.